AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Gallagher-Thompson, D Dal Canto, PG Jacob, T Thompson, LW
Citation: D. Gallagher-thompson et al., A comparison of marital interaction patterns between couples in which the husband does or does not have Alzheimer's disease, J GERONT B, 56(3), 2001, pp. S140-S150

Authors: Thompson, LW Coon, DW Gallagher-Thompson, D Sommer, BR Koin, D
Citation: Lw. Thompson et al., Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression, AM J GER PS, 9(3), 2001, pp. 225-240

Authors: Brinckerhoff, LH Thompson, LW Slingluff, CL
Citation: Lh. Brinckerhoff et al., Melanoma vaccines (vol 12, pg 163, 2000), CURR OPIN O, 13(5), 2001, pp. 413-413

Authors: Brinckerhoff, LH Thompson, LW Slingluff, GL
Citation: Lh. Brinckerhoff et al., Melanoma vaccines, CURR OPIN O, 12(2), 2000, pp. 163-173

Authors: Dodel, RC Du, Y Bales, KR Gao, F Eastwood, B Glazier, B Zimmer, R Cordell, B Hake, A Evans, R Gallagher-Thompson, D Thompson, LW Tinklenberg, JR Pfefferbaum, A Sullivan, EV Yesavage, J Altstiel, L Gasser, T Farlow, MR Murphy, GM Paul, SM
Citation: Rc. Dodel et al., alpha 2 macroglobulin and the risk of Alzheimer's disease, NEUROLOGY, 54(2), 2000, pp. 438-442

Authors: Steffen, AM Thompson, LW Gallagher-Thompson, D Koin, D
Citation: Am. Steffen et al., Physical and psychosocial correlates of hormone replacement therapy with chronically stressed postmenopausal women, J AG HEALTH, 11(1), 1999, pp. 3-26

Authors: Kittlesen, DJ Thompson, LW Gulden, PH Skipper, JCA Colella, TA Shabanowitz, J Hunt, DF Engelhard, VH Slingluff, CL
Citation: Dj. Kittlesen et al., Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: Implications for tumor vaccine development (vol 160, pg 2099, 1998), J IMMUNOL, 162(5), 1999, pp. 3106-3106

Authors: Brinckerhoff, LH Kalashnikov, VV Thompson, LW Yamshchikov, GV Pierce, RA Galavotti, HS Engelhard, VH Slingluff, CL
Citation: Lh. Brinckerhoff et al., Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: Implications for peptide vaccines, INT J CANC, 83(3), 1999, pp. 326-334

Authors: Gradman, TJ Thompson, LW Gallagher-Thompson, D
Citation: Tj. Gradman et al., Personality disorders and treatment outcome, LEA SER PER, 1999, pp. 69-94
Risultati: 1-9 |